Tremtelectogene empogeditemcel (trem-cel) may make gemtuzumab ozogamicin maintenance safer for patients with high-risk acute myeloid leukemia (AML), according to results of a phase 1/2 trial presented ...
Vontobel Holding Ltd. reduced its stake in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 23.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 9,467 shares of ...
The following is a summary of “Individual mHLA-DR trajectories in the ICU as predictors of early infections following liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback